Akari Therapeutics (AKTX) Earnings Date & Reports

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) built around novel, proprietary payloads utilizing powerful biology to attack cancer... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

AKTX is expected to report earnings to fall ∞% to -208 cents per share on December 04

Akari Therapeutics AKTX Stock Earnings Reports

Q3'26

Est.

$-2.09

Q2'26

Beat

by $1.39

Q1'26

Missed

by $1.29

Q4'25

Missed

by $4.81

Q3'25

Missed

by $0.09

The last earnings report on August 13 showed earnings per share of 0 cents, beating the estimate of -138 cents. With 4.14K shares outstanding, the current market capitalization sits at 19.10M.

View a ticker or compare two or three

AKTX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for AKTX